BlackRock launches iShares US biotech ETF

TER of 0.35%

Tom Eckett
clock • 1 min read

BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.

Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using a modified cap-weighted methodology. The top five constituents are capped at 8% of the total index, while the remaining holdings are capped at 4%. The top five holdings are Biogen, Amgen, Celgene Corp, Gilead Sciences and Regeneron Pharmaceuticals. Does recent tech sell-off signal 'beginning of the end' for turbo-charged rally? The firm said the market's focus on aging demographics ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on ETFs

HANetf said that demand for copper is likely to outstrip supply as the clean energy transition takes hold.

HANetf launches 'pure play' Article 8 copper mining ETF

Listed on the London Stock Exchange

Valeria Martinez
clock 07 December 2023 • 1 min read
iShares noted that after three months of outflows from high yield ETFs globally, in November investors injected record flows of $11.6bn into them.

iShares adds to fixed income suite with double ESG bond ETF launch

Exposure to high yield bonds

Cristian Angeloni
clock 07 December 2023 • 1 min read
JPMorgan Global Equity Premium Income UCITS ETF (JEPG) aims to offer investors 7-9% annualised income, paid monthly, with less volatility than its benchmark.

JP Morgan AM launches equity options-based ETF

Global Equity Premium Income UCITS ETF

clock 06 December 2023 • 1 min read